Out of stock

This item is currently unavailable

Wiley-Blackwell Novel Infectious Agents and the Central Nervous System (Novartis Foundation Symposia)

Out of stock

Price data last checked 19 day(s) ago - will refresh soon

View at Amazon

One email. No newsletter. No nudges.

Gone for 47 days. Could come back at any time — we're watching for you.

Out of stock 47 days · last price £90 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 72 days · 72 data points (no recent data)

Historical
Generating forecast…
£90.00 £85.50 £87.30 £89.10 £90.90 £92.70 £94.50 26 April 2026 13 May 2026 31 May 2026 18 June 2026 06 July 2026

Price Distribution

Price distribution over 72 days • 1 price levels

Days at Price
72 days 0 18 36 54 72 £90 Days at Price

Price Analysis

Most common price: £90 (72 days, 100.0%)

Price range: £90 - £90

Price levels: 1 different prices over 72 days

Description

Novel Infectious Agents and the Central Nervous System Chairman: F. Brown 1988 Certain neurological disorders, such as Creutzfeldt-Jakob disease, are clearly caused by an infectious agent, but the nature of this agent has yet to be determined. Scrapie is a disease of sheep that shows the same properties as these rare but fatal human diseases. A cardinal feature of the disorders is the exceptionally long incubation period, which makes investigation of the causative agent a long-term and costly process. Studies have been greatly facilitated by the experimental transmission of scrapie to rodents, and the isolation of strains of scrapie that have relatively short incubations. The elusive nature of the scrapie agent (it is extremely resistant to normal physicochemical methods of inactivation) has meant that numerous hypotheses have been proposed for its structure. The basic issue is whether it contains a genome encoding sufficient information to direct its own replication, and the nature of this putative informational molecule. This book presents the latest results on scrapie, including classical genetic studies, characterization of the major protein found in scrapie-associated fibrils, and experiments using the cloning and gene transfer techniques of molecular biology. The implications of the findings from animal studies for understanding the human disorders are explored, and the neuropathology in both animals and humans is described. There is also a report on the epidemiology of the human diseases, and a discussion of the various features shared by these infectious neurological disorders and Alzheimer's disease. Recent Ciba Foundation books: No 126 Selective neuronal death Chairman: H. Wisniewski ISBN 0 471 91092 9 No 128 Novel diarrhoea viruses Chairman: R. F. Bishop ISBN 0 471 91094 5 No 129 Autoimmunity and autoimmune disease Chairman: D. K. Peters ISBN 0 471 91095 3 No 130 Molecular approaches to human polygenic disease Chairman: D. J. Weatherall ISBN 0 471 91096 1 From the Back Cover Novel Infectious Agents and the Central Nervous System Chairman: F. Brown 1988 Certain neurological disorders, such as Creutzfeldt-Jakob disease, are clearly caused by an infectious agent, but the nature of this agent has yet to be determined. Scrapie is a disease of sheep that shows the same properties as these rare but fatal human diseases. A cardinal feature of the disorders is the exceptionally long incubation period, which makes investigation of the causative agent a long-term and costly process. Studies have been greatly facilitated by the experimental transmission of scrapie to rodents, and the isolation of strains of scrapie that have relatively short incubations. The elusive nature of the scrapie agent (it is extremely resistant to normal physicochemical methods of inactivation) has meant that numerous hypotheses have been proposed for its structure. The basic issue is whether it contains a genome encoding sufficient information to direct its own replication, and the nature of this putative informational molecule. This book presents the latest results on scrapie, including classical genetic studies, characterization of the major protein found in scrapie-associated fibrils, and experiments using the cloning and gene transfer techniques of molecular biology. The implications of the findings from animal studies for understanding the human disorders are explored, and the neuropathology in both animals and humans is described. There is also a report on the epidemiology of the human diseases, and a discussion of the various features shared by these infectious neurological disorders and Alzheimer?s disease. Recent Ciba Foundation books: No 126 Selective neuronal death Chairman: H. Wisniewski ISBN 0 471 91092 9 No 128 Novel diarrhoea viruses Chairman: R. F. Bishop ISBN 0 471 91094 5 No 129 Autoimmunity and autoimmune disease Chairman: D. K. Peters ISBN 0 471 91095 3 No 130 Molecular approaches to human polygenic diseas

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Neuronal Cell Death: Methods and Protocols: 1254 (Methods in Molecular Biology, 1254)
96% match

Neuronal Cell Death: Methods and Protocols: 1254 (Methods in Molecular Biology, 1254)

Humana

£81.09 09 Jul 2026
Academic Press Cancer Immunotherapy - Volume 164 Book
96% match

Academic Press Cancer Immunotherapy - Volume 164 Book

Academic Press

£118.69 18 Jul 2026
Autophagy Dysfunction in Alzheimer's Disease and Dementia
96% match

Autophagy Dysfunction in Alzheimer's Disease and Dementia

Academic Press

£99.35 17 Jul 2026
Neurodegenerative Disorders as Systemic Diseases
96% match

Neurodegenerative Disorders as Systemic Diseases

Springer

£107.85 08 Jul 2026
Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)
96% match

Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)

Academic Press

£113.59 10 Jul 2026
Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)
96% match

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Springer

£204.76 14 Jun 2026
Immunotherapy and Biomarkers in Neurodegenerative Disorders (Methods in Pharmacology and Toxicology)
96% match

Immunotherapy and Biomarkers in Neurodegenerative Disorders (Methods in Pharmacology and Toxicology)

Humana

£99.94 18 Jul 2026
Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107
96% match

Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107

Academic Press

£87.85 09 Jul 2026
A Review on Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics
96% match

A Review on Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics

Academic Press

£158.99 08 Jul 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
96% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£105.49 09 Jul 2026
Springer Neuron-Glia Interaction in Neuroinflammation - Vol 7
96% match

Springer Neuron-Glia Interaction in Neuroinflammation - Vol 7

Springer

£132.92 20 Jul 2026
Mitochondrial Neuropathies: Volume 145 (International Review of Neurobiology, Volume 145)
96% match

Mitochondrial Neuropathies: Volume 145 (International Review of Neurobiology, Volume 145)

Academic Press

£134.99 29 Jun 2026
Movement Disorders Curricula
96% match

Movement Disorders Curricula

Springer

£257.02 04 Jul 2026
Neurodegenerative Diseases: Molecular and Cellular Mechanisms and Therapeutic Advances (Gwumc Department of Biochemistry and Molecular Biology Annual Spring Symposia)
96% match

Neurodegenerative Diseases: Molecular and Cellular Mechanisms and Therapeutic Advances (Gwumc Department of Biochemistry and Molecular Biology Annual Spring Symposia)

Springer

£140.42 17 Jul 2026
Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)
96% match

Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)

Academic Press

£79.99 10 Jul 2026
Academic Press Molecular Biology of Neurodegenerative Diseases
96% match

Academic Press Molecular Biology of Neurodegenerative Diseases

Academic Press

£114.99 18 Jul 2026
Humana NMDA Receptors: Methods and Protocols 1677 Book
96% match

Humana NMDA Receptors: Methods and Protocols 1677 Book

Humana

£103.26 18 Jul 2026
Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (International Society of Neuropathology Series)
96% match

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (International Society of Neuropathology Series)

Wiley-Blackwell

£137.96 14 Jun 2026
Neurodegenerative Diseases: Unifying Principles
96% match

Neurodegenerative Diseases: Unifying Principles

Oxford University Press

£152.90 13 Jul 2026
Humana Molecular Neurovirology - Pathogenesis of Viral CNS Infections
96% match

Humana Molecular Neurovirology - Pathogenesis of Viral CNS Infections

Humana

£90.73 20 Jul 2026
Cerebrospinal Fluid Biomarkers: 168 (Neuromethods, 168)
96% match

Cerebrospinal Fluid Biomarkers: 168 (Neuromethods, 168)

Humana

£140.56 17 Jun 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
96% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£81.54 13 Jul 2026
Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)
96% match

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)

CRC Press

£205.49 14 Jun 2026
Neurobiology of Disease
96% match

Neurobiology of Disease

Academic Press

£162.38 16 Jun 2026